Atlas Trials

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

Clinical trial NCT01467882 · COMPLETED

Trial details

NCT number
NCT01467882
Sponsor
Debiopharm International SA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Central Precocious Puberty
Start date
2012-04-01
Primary completion
2013-08-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.